Del Global Technologies Announces Supply Agreements with Novation; Del Medical Imaging Inks Deals with Major National Group Purchasing Organization.

VALHALLA, N.Y. -- Del Global Technologies Corp. (DGTC) ("Del Global" or "the Company") today announced that its subsidiary Del Medical Imaging Corporation ("Del Medical"), a leading manufacturer of general purpose radiographic imaging systems, has signed two agreements with Novation, the supply company of VHA Inc. and the University HealthSystem Consortium (UHC).

Del Medical has been awarded a dual-source agreement for general radiology (non-acute care) equipment and a multi-source agreement for digital radiography systems and accessories. Through these three-year agreements, VHA and UHC member facilities will be able to access discounted pricing on Del Medical radiographic and digital radiography systems for all of their hospital, outpatient clinic, and medical center sites.

Based in Irving, Texas, Novation was established in January 1998 through a combination of the supply programs of VHA and UHC, two national health care alliances. Novation serves the purchasing needs of more than 2,500 members and affiliates of VHA and UHC. These organizations used Novation contracts to purchase more than $23 billion in supplies in 2004.

Novation awarded the contracts through its public competitive bid process, with input from member surveys, and member-based Novation Diagnostic Imaging, Capital and Facilities, and Anesthesia Councils, and the Novation Diagnostic Imaging Capital Equipment Task Force.

"We are very excited about this relationship with Novation, as well as the opportunity to offer what we believe is the gold standard in general radiographic and digital radiography equipment to VHA and UHC members nationwide," said Scott Loehrke, Vice President, Sales and Marketing at Del Medical. "We believe the opportunity for Novation customers to purchase product from our extensive line will be mutually beneficial."

Walter F. Schneider, President and Chief Executive Officer of Del Global, commented, "Del Medical's business continues to grow as hospitals look for more cost-effective alternatives for their general radiographic needs. DEL Medical's product lines are known for their reliability and high quality diagnostic imaging capabilities. The addition of a market leading technology in the Epex DR product line completes Del Medical's offerings into the radiographic marketplace."

All of Del Medical's hospital configured radiographic systems are fully upgradeable to provide digital imaging capabilities. The Company sells its products worldwide through independent distributors.

ABOUT DEL GLOBAL TECHNOLOGIES

Del Global Technologies Corp. is primarily engaged in the design, manufacture and marketing of cost-effective medical imaging and diagnostic systems consisting of stationary and portable x-ray systems, radiographic/fluoroscopic systems, dental imaging systems and proprietary high-voltage power conversion subsystems for medical and other critical industrial applications. Through its RFI subsidiary, Del Global manufactures electronic filters, high voltage capacitors, pulse modulators, transformers and reactors, and a variety of other products designed for industrial, medical, military and other commercial applications.

Statements about future results made in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and the current economic environment. Del Global cautions that these statements are not guarantees of future performance. These statements involve a number of risks and uncertainties that are difficult to predict, including, but not limited to: the ability of Del Global to implement its business plan; the ability of Del Medical to deliver on all orders related to its supply agreement with Novation; retention of management; changing industry and competitive conditions; obtaining anticipated operating efficiencies; securing necessary capital facilities; favorable determinations in various legal matters; market and operating risks from foreign currency exchange exposures; and favorable general economic conditions. Actual results could differ materially from those expressed or implied in the forward-looking statements. Important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements are specified in the Company's filings with the Securities and Exchange Commission.